Falciform ligament appendagitis after Roux-en-Y bypass surgery mimicking acute cholecystitis

  1. Lee K Rousslang ,
  2. McHuy F McCoy and
  3. C Frank Gould
  1. Department of Radiology, Tripler Army Medical Center, Medical Center, Hawaii, USA
  1. Correspondence to Dr Lee K Rousslang; lee.k.rousslang.civ@mail.mil

Publication history

Accepted:07 Jul 2020
First published:17 Aug 2020
Online issue publication:17 Aug 2020

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

Fatty falciform ligament appendage torsion (F-FLAT) is a rare type of intraperitoneal focal fat infarction that involves torsion of a fatty appendage of the falciform ligament. It may cause severe pain, mimicking an acute abdomen, but is typically self-limited and does not require hospitalisation or surgery. As a type of intraperitoneal focal fat infarction, it shares many of the same physiological, clinical and radiological features of epiploic appendagitis. To our knowledge, F-FLAT has not previously been reported in a patient following a laparoscopic Roux-en-Y gastric bypass surgery. Identifying falciform ligament appendagitis is critical because it can prevent unnecessary hospitalisation, follow-up studies and surgery.

Background

The incidence of fatty falciform ligament appendage torsion (F-FLAT) is extremely rare, with only 10 cases being reported on imaging in the literature to date.1–9 There are a handful of cases identified by surgical exploration without imaging, mostly before 1980.10–14 Like other intraperitoneal focal fat infarctions (IFFIs), falciform ligament appendagitis is caused by torsion of an abnormally long lipomatous appendage leading to ischemia, infarction and ultimately aseptic fat necrosis. The presentation is variable but classically involves acute or subacute epigastric pain that does not radiate, with a low-grade fever and mild leukocytosis. The major risk factor for IFFI is obesity, specifically, increased abdominal visceral adipose tissue, which is more common in men.15 For unknown reasons, obese individuals tend to have longer, more prominent appendages that are presumably more prone to torsion.16 Given the rising rates of obesity and bariatric surgery, it is becoming increasingly important to identify this medical oddity.

Case presentation

A 46-year-old obese woman with a history of laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery for obesity 10 months prior, presented to the emergency department with 3 days of worsening right-upper-quadrant (RUQ) pain described as ‘stabbing‘' that was exacerbated by meals, and 8/10 in severity. On physical examination she demonstrated exquisite tenderness to palpation in the right upper quadrant and epigastric regions, with guarding but no rebound tenderness. Basic laboratory tests revealed elevated liver enzymes with aspartate aminotransferase (AST) of 56 units/L (normal: 5–34 units/L), alanine aminotransferase (ALT) of 63 units/L (normal: 10–55 units/L), alkaline phosphatase of 164 units/L (normal: 40–150 units/L), and neutrophilia (absolute neutrophil count 5.63×103 neutrophils/µL).

Investigations

Out of concern for acute cholecystitis, a right upper quadrant ultrasound was performed and it was negative for the classical signs of acute cholecystitis (gallbladder wall thickening, common bile duct dilatation, etc) but did show a small polyp and a 3 mm hyperechoic stone in the gallbladder neck, with the twinkle artefact (figure 1). A sonographic Murphy’s sign was equivocal due to the patient’s exquisite tenderness to even mild palpation. A CT was then performed that demonstrated an 18.8×9.6 mm ovoid focus of fatty necrosis on the falciform ligament consistent with a torsed fatty appendage of the falciform ligament (figure 2). On this finding, a hepatobiliary iminodiacetic acid scan that had been scheduled was cancelled.

Figure 1

Abdominal ultrasonography of the gallbladder along the long axis (left) demonstrates a small polyp at the fundus, and a 3 mm non-obstructing stone near the neck of the gallbladder (arrow) that demonstrates the Twinkle artefact on colour Doppler (right).

Figure 2

Axial (A), coronal (B) and sagittal (C) abdominal CT with intravenous contrast demonstrates the ovoid hypodensity with a well-demarcated hyperdense ring near the junction of the right and left lobes of the liver anteriorly, consistent with a fatty falciform ligament appendage torsion (arrows). A ‘central dot’ sign can be appreciated on the coronal (D) view (arrow).

Differential diagnosis

The presentation of F-FLAT is highly variable and can present as acute abdominal pain with or without fever, anorexia, nausea, vomiting or radiation to the back.3 As such, it can mimic surgical or post-surgical complications such as marginal ulcers or cholecystitis17 or nonsurgical conditions such as gastritis, hepatitis or pancreatitis.

Our patient had exquisite right upper quadrant abdominal pain that was exacerbated by meals, radiated to the back and neutrophilia, making the presentation highly suspicious for acute cholecystitis. Her weight, gender, age and premenopausal status are also known risk factors for acute cholecystitis. Moreover, cholecystitis is a common occurrence after LRYGB surgery, with 10.6% of patients ultimately requiring cholecystectomy.17 The incidence of symptomatic gallstones is highest in the first 6 months after LRYGB surgery, and the mean time to cholecystectomy is 19.1 months after surgery.17 Ultimately, a right-upper-quadrant ultrasound and abdominal CT did not demonstrate evidence of cholecystitis (figure 1), and the diagnosis of F-FLAT was made.

The perigastric pain of F-FLAT can also mimic other acute surgical conditions such as a perforated gastric or marginal ulcer. This was especially concerning as our patient had a recent Roux-en-Y surgery, the most common complication of which is ulcer formation near the anastomosis (marginal ulcer) that occurs in up to 16% of patients, and can potentially perforate.18 Our patient underwent endoscopy as part of the diagnostic workup that did not demonstrate marginal ulcers as the cause of her pain.

Anastomotic dehiscence was also on the differential. To our knowledge this is the first case of F-FLAT in a patient with a prior LRYGB surgery. Her stable hemodynamics, lack of systemic symptoms such as fever, absence of imaging findings of perforation on CT, and relatively benign bloodwork suggested against dehiscence as the aetiology of her pain.

F-FLAT with prandial pain, such as in our patient, can also mimic nonsurgical conditions such as biliary colic, gastritis, hepatitis or pancreatitis. Although she had elevated liver enzymes, the relatively modest increase in AST, ALT and alkaline phosphatase, as well as absence of systemic symptoms such as fever, was less consistent with hepatitis. Additionally, her hepatitis A, B and C serologies were negative for infection. To our knowledge, there has been only one other case of F-FLAT that presented with elevated liver enzymes and hepatitis.9

Treatment

Unlike the surgical conditions it mimics, F-FLAT should be managed conservatively, as most cases resolved completely within 3–14 days.1 2 19 Treatment is typically with non-steroidal anti-inflammatory medications (NSAIDs), and surgery is warranted only in cases where symptoms fail to resolve with conservative therapy, or a rare complication develops, such as inability to tolerate oral intake, abscess or gangrenous necrosis.5 In our patient, NSAIDs were avoided due to the risk of marginal ulcer formation, a common complication of LRYGB surgery, and she was instead given acetaminophen and oxycodone for pain relief with good effect.

Outcome and follow-up

Two weeks after the initial presentation, the patient reported resolution of her pain, and a repeat CT demonstrated significant interval reduction in the size of the F-FLAT (figure 3).

Figure 3

Repeat axial CT with intravenous contrast 2 weeks later (A) demonstrates a marked reduction in the size of the fatty falciform ligament appendage torsion (F-FLAT) compared with the initial CT (B) (arrows). CT in the sagittal (C) and coronal (D) planes also demonstrates improvement of the F-FLAT.

Discussion

Contrast-enhanced abdominal CT is the gold standard to diagnose F-FLAT, as well as to monitor for resolution.19 On CT, F-FLAT appears as a well-demarcated ovoid hypodensity with a hyperenhancing ring.1 2 It may occasionally show a ‘central-dot sign‘' representing the hyperdense thrombosed vein in the centre of the hypodense lipomatous tissue.1 2 9 Ultrasound is a useful adjunct and may demonstrate a non-compressible, hyperechoic ovoid mass that does not variate with respiration, consistent with an extraperitoneal mass.5 9

Our patient’s presentation was consistent with previously documented cases of F-FLAT, as all previous cases involved either RUQ or epigastric abdominal pain.1–14 Additionally, leukocytosis (typically neutrophilia) is a common finding that was present in four of eight patients with F-FLAT for whom labs were available.1–3 5 6 8–10 One patient had labs concerning for hepatitis with elevated liver enzymes including AST, ALT, and direct and indirect bilirubin of 3058 IU/L, 1567 IU/L, 2.2 mg/dL and 1.5 mg/dL, respectively.9 (Reference ranges were not provided.) Lastly, one prior patient had isolated elevation in gamma-glutamyl transferase.6

The majority of patients with unequivocal IFFI findings on CT undergo unnecessary further workup, including additional imaging and laboratory tests.1 2 Moreover, a comprehensive review of the literature demonstrates that half (5 out of 10) of these patients underwent unnecessary surgery (appendagectomy), likely because of the rarity and lack of awareness of this anomaly.1 4–7 To our knowledge, F-FLAT without CT or US imaging has only been diagnosed surgically.10–14 IFFI after gastric bypass has been reported,20 but gastric bypass has not been proven to be a risk factor per se, likely because of the rarity of the condition. Given the recent projection that half of Americans will be obese by 2030, and the increasing number of bariatric surgery being performed, it is reasonable to conclude that F-FLAT will become increasingly commonplace.21

Learning points

  • Obesity is the major risk factor for intraperitoneal focal fat infarction .

  • Non-steroidal anti-inflammatory medications should be avoided after laparoscopic Roux-en-Y gastric bypass due to the risk of marginal ulcers, but acetaminophen and opiates may be appropriate.

  • With rising rates of obesity and bariatric surgery being performed, it is reasonable to conclude that fatty falciform ligament appendage torsion (F-FLAT) will become increasingly commonplace.

  • Although F-FLAT is a very rare condition, it is important to consider in a patient with non-specific abdominal pain and risk factors, as its identification can prevent unnecessary workup, hospitalisation and surgery.

Footnotes

  • Contributors As lead author, I, LKR, performed the majority of the writing and background research involved with the manuscript, including the summary, background, case presentation, differential diagnosis, treatment, outcome, discussion and learning points. MHFM helped with the literature search and edited the manuscript, including the addition of his own written contribution in the background, case presentation and discussion. He also performed the initial CT interpretation. CFG oversaw the entire process, finalised the radiological reads involved, provided edits including his own writing in the manuscript and also determined the important aspects of the case to be highlighted, including writing in the case presentation, discussion and learning points.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Disclaimer The views expressed in this manuscript are those of the authors and do not reflect the official policy or position of the Department of the Army, Department of Defense, or the United States Government. The authors have no financial, personal or other vested interests in the information contained within this document.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer